MX2011004174A - Metodos y composiciones para diagnosis y prognosis de lesion renal e insuficiencia renal. - Google Patents
Metodos y composiciones para diagnosis y prognosis de lesion renal e insuficiencia renal.Info
- Publication number
- MX2011004174A MX2011004174A MX2011004174A MX2011004174A MX2011004174A MX 2011004174 A MX2011004174 A MX 2011004174A MX 2011004174 A MX2011004174 A MX 2011004174A MX 2011004174 A MX2011004174 A MX 2011004174A MX 2011004174 A MX2011004174 A MX 2011004174A
- Authority
- MX
- Mexico
- Prior art keywords
- soluble
- methods
- growth factor
- receptor
- ligand
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Abstract
La presente invención es concerniente con métodos y composiciones para el monitoreo, diagnosis, prognosis y determinación de regímenes de tratamiento en sujetos que sufren de o sospechosos de tener lesión renal. En particular, la invención es concerniente con el uso de análisis que detectan uno o más marcadores seleccionados del grupo que consiste de aspartato aminotransferasa citoplásmica, miembro 5 de la superfamilia del receptor del factor de necrosis de tumor soluble, ligando de CD40 soluble, porción de quimiocina 16 C-X-C soluble, S100-A12, Eotaxina, E-selectina soluble, fibronectina, factor estimulador de colonia de granulocito, factor estimulador de colonia de granulocito-macrófago, factor 2 de crecimiento de enlace de heparina, receptor del factor de crecimiento de hepatocito soluble, antagonita de receptor de interleucina 1, interleucina-1 beta, interleucina-10, interleucina-15, interleucina-3, mieloperoxidasa, nidogen-1, receptor 1 de lipoproteína de baja densidad oxidado soluble, papalisina-1, ligando 1 de glicoproteina de P-selectina soluble, antileucoproteinasa, ligando de Kit soluble, inhibidor de tejido de, metaloproteinasa 1, inhibidor de tejido de metaloproteinasa 2, factor de necrosis de tumor soluble, molécula 1 de adhesión celular vascular soluble y factor A de crecimiento endotelial vascular como biomarcadores de diagnóstico y prognóstico en lesiones renales.
Applications Claiming Priority (30)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10730408P | 2008-10-21 | 2008-10-21 | |
US10729008P | 2008-10-21 | 2008-10-21 | |
US10730108P | 2008-10-21 | 2008-10-21 | |
US10728108P | 2008-10-21 | 2008-10-21 | |
US10729708P | 2008-10-21 | 2008-10-21 | |
US11302108P | 2008-11-10 | 2008-11-10 | |
US11309608P | 2008-11-10 | 2008-11-10 | |
US11310208P | 2008-11-10 | 2008-11-10 | |
US11304508P | 2008-11-10 | 2008-11-10 | |
US11305608P | 2008-11-10 | 2008-11-10 | |
US11305008P | 2008-11-10 | 2008-11-10 | |
US11308308P | 2008-11-10 | 2008-11-10 | |
US11501908P | 2008-11-14 | 2008-11-14 | |
US11501708P | 2008-11-14 | 2008-11-14 | |
US11502208P | 2008-11-14 | 2008-11-14 | |
US11505708P | 2008-11-15 | 2008-11-15 | |
US11504808P | 2008-11-15 | 2008-11-15 | |
US11504508P | 2008-11-15 | 2008-11-15 | |
US11505108P | 2008-11-15 | 2008-11-15 | |
US11504708P | 2008-11-15 | 2008-11-15 | |
US11504408P | 2008-11-15 | 2008-11-15 | |
US11714008P | 2008-11-22 | 2008-11-22 | |
US11715408P | 2008-11-22 | 2008-11-22 | |
US11716708P | 2008-11-22 | 2008-11-22 | |
US11715208P | 2008-11-22 | 2008-11-22 | |
US11714608P | 2008-11-22 | 2008-11-22 | |
US11715708P | 2008-11-22 | 2008-11-22 | |
US11714108P | 2008-11-22 | 2008-11-22 | |
US11717208P | 2008-11-22 | 2008-11-22 | |
PCT/US2009/061561 WO2010048346A1 (en) | 2008-10-21 | 2009-10-21 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2011004174A true MX2011004174A (es) | 2011-09-27 |
Family
ID=42119666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011004174A MX2011004174A (es) | 2008-10-21 | 2009-10-21 | Metodos y composiciones para diagnosis y prognosis de lesion renal e insuficiencia renal. |
Country Status (13)
Country | Link |
---|---|
US (3) | US8778615B2 (es) |
EP (4) | EP3974836A1 (es) |
JP (4) | JP2012506537A (es) |
KR (1) | KR101760314B1 (es) |
CN (6) | CN104391116B (es) |
AU (1) | AU2009308497B2 (es) |
BR (1) | BRPI0919640A2 (es) |
CA (1) | CA2740788C (es) |
ES (1) | ES2836218T3 (es) |
HK (1) | HK1159755A1 (es) |
MX (1) | MX2011004174A (es) |
NZ (3) | NZ607703A (es) |
WO (1) | WO2010048346A1 (es) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG187453A1 (en) | 2008-01-18 | 2013-02-28 | Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
GB0807214D0 (en) | 2008-04-21 | 2008-05-28 | Belfast Health And Social Care | Biomarkers |
BRPI0917711A2 (pt) | 2008-08-28 | 2017-06-20 | Astute Medical Inc | método para avaliar o estado renal em um paciente, e, uso de um ou mais marcadores de lesão renal |
WO2010025434A1 (en) * | 2008-08-29 | 2010-03-04 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
EP3974836A1 (en) | 2008-10-21 | 2022-03-30 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CA2740923A1 (en) * | 2008-10-21 | 2010-04-29 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
BRPI0922021A2 (pt) | 2008-11-10 | 2019-09-24 | Astute Medical Inc | método para avaliar a condição renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal |
NZ604873A (en) * | 2008-11-22 | 2014-05-30 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US9229010B2 (en) | 2009-02-06 | 2016-01-05 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
EP2462440B1 (en) | 2009-08-07 | 2017-05-17 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
NZ599105A (en) * | 2009-09-21 | 2014-08-29 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
EA201290192A1 (ru) | 2009-11-07 | 2013-02-28 | Астьют Медикал, Инк. | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности |
MX2012005210A (es) * | 2009-11-07 | 2012-08-03 | Astute Medical Inc | Metodos y composiciones para diagnostico y pronostico de lesion renal y falla renal. |
US20120156701A1 (en) * | 2009-12-20 | 2012-06-21 | Joseph Anderberg | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CA2784889C (en) | 2009-12-20 | 2018-06-19 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
NZ700695A (en) | 2010-02-05 | 2016-05-27 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US9029093B2 (en) | 2010-02-26 | 2015-05-12 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
EP2585825B1 (en) | 2010-06-23 | 2018-01-10 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
AU2011269775B2 (en) | 2010-06-23 | 2015-01-15 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
AU2011279712B2 (en) * | 2010-07-14 | 2015-06-18 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CN104569395A (zh) * | 2010-07-19 | 2015-04-29 | 霍夫曼-拉罗奇有限公司 | 鉴定响应抗癌疗法的可能性升高的患者的方法 |
US20120053073A1 (en) | 2010-07-23 | 2012-03-01 | President And Fellows Of Harvard College | Methods for Detecting Signatures of Disease or Conditions in Bodily Fluids |
WO2012012704A2 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting kidney-associated diseases or conditions |
CA2806293A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
MX2013000917A (es) | 2010-07-23 | 2013-07-05 | Harvard College | Metodos para detectar las enfermedades o condiciones usando celulas fagociticas. |
CA2806304A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
WO2012094658A2 (en) * | 2011-01-08 | 2012-07-12 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
WO2012094657A1 (en) * | 2011-01-08 | 2012-07-12 | Astute Medical, Inc. | Method and compositions for diagnosis and prognosis of renal injury and renal failure |
EP2668497B1 (en) * | 2011-01-26 | 2020-03-25 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Urine biomarkers for prediction of recovery after acute kidney injury : proteomics |
EP2518512A1 (en) | 2011-04-29 | 2012-10-31 | Medizinische Universität Wien | Method for indicating a renal disease in a patient by determining at least one protein in isolated HDL |
EP2707524A4 (en) * | 2011-05-12 | 2015-05-06 | Astute Medical Inc | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency |
EP3489690A1 (en) * | 2011-08-26 | 2019-05-29 | Astute Medical, Inc. | Methods and compositions for evaluation of the renal status |
ES2734494T3 (es) * | 2011-12-08 | 2019-12-10 | Astute Medical Inc | Métodos y usos para el diagnóstico de una lesión renal y de una insuficiencia renal |
WO2013113018A1 (en) * | 2012-01-28 | 2013-08-01 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CA2865563A1 (en) * | 2012-02-27 | 2013-09-06 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US20150010929A1 (en) * | 2012-02-27 | 2015-01-08 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
GB201210571D0 (en) | 2012-06-14 | 2012-08-01 | Belfast Health And Social Care Trust | Predictive biomarker |
GB201210587D0 (en) * | 2012-06-14 | 2012-08-01 | Belfast Health And Social Care Trust | Predictive biomarker |
GB201214440D0 (en) * | 2012-08-13 | 2012-09-26 | Randox Lab Ltd | Kidney disease biomarker |
EP2719771A1 (en) * | 2012-10-11 | 2014-04-16 | Ciber de Enfermedades Respiratorias (CIBERES) | Marker for assessing the risk of developing acute kidney injury |
CA3158996A1 (en) | 2013-01-17 | 2014-07-24 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US11585814B2 (en) | 2013-03-09 | 2023-02-21 | Immunis.Ai, Inc. | Methods of detecting prostate cancer |
EP2965077B1 (en) | 2013-03-09 | 2022-07-13 | Harry Stylli | Methods of detecting cancer |
MX2016001573A (es) | 2013-08-07 | 2016-09-07 | Astute Medical Inc | Ensayos para timp2 con mejor rendimiento en muestras biológicas. |
EP2843414B1 (en) * | 2013-08-26 | 2018-09-19 | Roche Diagniostics GmbH | Marker for statin treatment stratification in heart failure |
WO2015084939A1 (en) | 2013-12-03 | 2015-06-11 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
SG11201607487UA (en) * | 2014-03-21 | 2016-10-28 | Sanofi Aventis Deutschland | New markers for the assessment of the risk for development of a cardiovascular disorder |
AU2015314813B2 (en) | 2014-09-11 | 2022-02-24 | Immunis.Ai, Inc. | Methods of detecting prostate cancer |
ES2943579T3 (es) | 2014-12-18 | 2023-06-14 | Astute Medical Inc | Procedimientos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal |
US10611123B2 (en) | 2015-02-20 | 2020-04-07 | 3M Innovative Properties Company | Silicone carbonate polymers as release layers for pressure sensitive adhesive containing articles |
US11243202B2 (en) | 2015-04-09 | 2022-02-08 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
WO2016176483A1 (en) * | 2015-04-28 | 2016-11-03 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US11506672B2 (en) * | 2015-06-11 | 2022-11-22 | Astute Medical, Inc. | Follistatin-related protein 3 for diagnosis and prognosis of renal injury and renal failure |
CN109844526A (zh) | 2016-06-06 | 2019-06-04 | 机敏医药股份有限公司 | 使用胰岛素样生长因子结合蛋白7和金属蛋白酶2的组织抑制剂管理急性肾损伤 |
CN106370856B (zh) * | 2016-08-16 | 2019-04-02 | 北京师范大学 | 肺纤维化的尿液蛋白标志物及其在诊断和预后中的用途 |
JP7100030B2 (ja) | 2016-10-28 | 2022-07-12 | アスチュート メディカル,インコーポレイテッド | 腎機能の改善のためのtimp-2に対する抗体の使用 |
JP2018096710A (ja) * | 2016-12-08 | 2018-06-21 | 国立大学法人金沢大学 | 血中タンパク質を測定することにより、ネフローゼ症候群の疾患活動性を判定する方法 |
WO2018117011A1 (ja) | 2016-12-19 | 2018-06-28 | 国立大学法人大阪大学 | インビトロでのIgM型メモリーB細胞分化培養系を用いた臓器移植後抗体関連型拒絶反応の早期診断法 |
WO2018145117A1 (en) | 2017-02-06 | 2018-08-09 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
JP7315466B2 (ja) | 2017-04-05 | 2023-07-26 | アスチュート メディカル,インコーポレイテッド | 生体試料中において改善した性能を有する、timp2に関するアッセイ |
CN109975553B (zh) * | 2017-12-28 | 2020-10-09 | 北京师范大学 | 慢性阻塞性肺病的尿液蛋白标志物及其在早期诊断中的用途 |
US11435364B2 (en) | 2018-05-24 | 2022-09-06 | Renibus Therapeutics, Inc. | Methods of treating patients at risk for renal injury and renal failure |
KR102319190B1 (ko) * | 2018-12-19 | 2021-10-29 | 서울대학교병원 | 신장 질환 진단용 바이오 마커 |
KR102077987B1 (ko) * | 2018-12-19 | 2020-02-17 | 주식회사 헬릭스미스 | 신장 질환 진단용 바이오 마커 |
RU2726314C1 (ru) * | 2019-11-15 | 2020-07-14 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Тихоокеанский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ раннего прогнозирования риска острого повреждения почек у пациентов с ишемической болезнью сердца после реваскуляризации миокарда методом аортокоронарного шунтирования |
CN115469026B (zh) * | 2022-07-14 | 2023-10-20 | 中日友好医院(中日友好临床医学研究所) | 用于检测环孢素a肾毒性相关标志物的检测试剂、试剂盒及其用途 |
Family Cites Families (149)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1429031A1 (ru) | 1986-06-20 | 1988-10-07 | Калининский Государственный Медицинский Институт | Способ дифференциальной диагностики гломерулонефрита и пиелонефрита |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
AU658374B2 (en) | 1990-09-14 | 1995-04-13 | Biosite Diagnostics Incorporated | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays |
US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
EP0585310B1 (en) | 1991-04-10 | 1999-03-17 | Biosite Diagnostics Inc. | Crosstalk inhibitors and their uses |
ES2150915T3 (es) | 1991-04-12 | 2000-12-16 | Biosite Diagnostics Inc | Nuevos conjugados y dosificados destinados para la deteccion simultanea de ligandos multiples. |
US6019944A (en) | 1992-05-21 | 2000-02-01 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
JP3569577B2 (ja) * | 1995-09-04 | 2004-09-22 | 株式会社いかがく | 腎・尿路系疾患の鑑別診断用キット |
JP3599895B2 (ja) * | 1996-04-05 | 2004-12-08 | 株式会社いかがく | 糖尿病性腎症および糸球体腎炎の早期診断用キット |
US6498142B1 (en) * | 1996-05-06 | 2002-12-24 | Curis, Inc. | Morphogen treatment for chronic renal failure |
ES2258793T5 (es) * | 1996-05-24 | 2010-01-25 | Biogen Idec Ma Inc. | Moduladores de la regeneracion tisular. |
US5753455A (en) | 1996-09-03 | 1998-05-19 | Bayer Corporation | Method for the detection of lysozyme using a protein error indicator dye in conjunction with an alkane sulfonic acid |
US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
JP2002512524A (ja) | 1997-06-03 | 2002-04-23 | 財団法人相模中央化学研究所 | 膜貫通ドメインを有するヒト蛋白質及びそれをコードするdna |
US20060223077A1 (en) * | 1997-06-06 | 2006-10-05 | Human Genome Sciences, Inc. | 207 human secreted proteins |
US6218122B1 (en) * | 1998-06-19 | 2001-04-17 | Rosetta Inpharmatics, Inc. | Methods of monitoring disease states and therapies using gene expression profiles |
US6958147B1 (en) * | 1998-10-26 | 2005-10-25 | Licentia Ltd | Use of VEGF-C to prevent restenosis |
MXPA01006404A (es) * | 1998-12-21 | 2003-06-06 | Univ Monash | Deteccion y tratamiento de enfermedad renal. |
WO2001028500A2 (en) * | 1999-10-18 | 2001-04-26 | The Board Of Trustees Of The University Of Arkansas | Uses of antileukoprotease in carcinoma |
EP1282823B1 (en) | 2000-05-17 | 2014-05-07 | Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO | Proteolytic enzymes for the diagnosis of kidney disorders |
US20020115626A1 (en) | 2000-05-25 | 2002-08-22 | Luca Rastelli | Method of detecting inflammatory lung disorders |
RU2180965C1 (ru) | 2000-07-03 | 2002-03-27 | Габбасова Наталья Вадимовна | Способ дифференциальной диагностики заболеваний почек |
AU2002216273A1 (en) * | 2000-12-29 | 2002-07-16 | Oxford Glycosciences (Uk) Limited | Proteins, genes and their use for diagnosis and treatment of kidney response |
CA2442820A1 (en) * | 2001-03-29 | 2002-10-10 | Van Andel Institute | Microarray gene expression profiling in clear cell renal cell carcinoma: prognosis and drug target identification |
US20070015146A1 (en) * | 2001-05-22 | 2007-01-18 | Gene Logic, Inc. | Molecular nephrotoxicology modeling |
US7235358B2 (en) * | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
US20030003588A1 (en) * | 2001-06-28 | 2003-01-02 | Comper Wayne D. | Method for kidney disease detection by protein profiling |
DE60237455D1 (de) * | 2001-07-12 | 2010-10-07 | Kyowa Medex Co Ltd | Verfahren zur quantifizierung von denaturiertem lipoprotein |
HUP0400659A3 (en) * | 2001-07-24 | 2005-06-28 | Zhu Zhou Woodbridge | Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
US6784154B2 (en) * | 2001-11-01 | 2004-08-31 | University Of Utah Research Foundation | Method of use of erythropoietin to treat ischemic acute renal failure |
US8404229B2 (en) * | 2001-12-07 | 2013-03-26 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to treat acute tubular necrosis |
GB0130557D0 (en) | 2001-12-20 | 2002-02-06 | Serono Internat S A | Proteins |
AU2003219275B2 (en) | 2002-03-07 | 2008-01-24 | Cambridge Enterprise Ltd | SCD fingerprints |
EP1532268A4 (en) * | 2002-03-21 | 2006-07-05 | Yissum Res Dev Co | PERIPHERAL BLOOD CELL MARKERS USEFUL IN THE DIAGNOSIS OF MULTIPLE SCLEROSIS AND METHODS AND KITS COMPRISING SUCH MARKERS |
US7138230B2 (en) * | 2002-12-06 | 2006-11-21 | Renovar, Inc. | Systems and methods for characterizing kidney diseases |
US7138229B2 (en) * | 2002-12-06 | 2006-11-21 | Renovar, Inc. | Systems and methods for characterizing kidney diseases |
US20040029200A1 (en) * | 2002-05-22 | 2004-02-12 | Thomas Weimbs | Method and kits for the detection of renal cell carcinoma in a biological fluid of a patient |
AU2003281287A1 (en) | 2002-07-04 | 2004-01-23 | Oxford Glycosciences (Uk) Ltd | Toxicity markers |
US6941172B2 (en) * | 2002-11-18 | 2005-09-06 | Zvi Nachum | Method and device for restoring kidney function using electromagnetic stimulation |
US20060063156A1 (en) * | 2002-12-06 | 2006-03-23 | Willman Cheryl L | Outcome prediction and risk classification in childhood leukemia |
JP2005120070A (ja) | 2003-03-10 | 2005-05-12 | Taisho Pharmaceut Co Ltd | エラスターゼ遊離抑制剤及び脳梗塞治療薬 |
CN1791797A (zh) * | 2003-03-27 | 2006-06-21 | 儿童医院医疗中心 | 用于检测肾小管细胞损伤的早发的方法和试剂盒 |
US7354584B2 (en) * | 2003-04-11 | 2008-04-08 | Medimmune, Inc. | Recombinant IL-9 antibodies |
WO2005002416A2 (en) * | 2003-06-04 | 2005-01-13 | Joslin Diabetes Center, Inc. | Predictors of renal disease |
US20050148029A1 (en) * | 2003-09-29 | 2005-07-07 | Biosite, Inc. | Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes |
GB0329288D0 (en) * | 2003-12-18 | 2004-01-21 | Inverness Medical Switzerland | Monitoring method and apparatus |
US20070280930A1 (en) | 2004-03-17 | 2007-12-06 | Kasper Mathias Antoon Rouschop | Cd44-Targeting for Reducing/Preventing Ischemia-Reperfusion-Injury |
BRPI0510266A (pt) * | 2004-04-26 | 2007-10-30 | Childrens Medical Center | métodos para a detecção de uma doença ou distúrbio angiogênico em um indivìduo, para a detecção de cáncer em um indivìduo, para o tratamento de um indivìduo afetado com uma doença ou distúrbio angiogênico, para a determinação da probabilidade de eficácia de uma terapia anti-angiogênica, para a determinação da eficácia de uma terapia de teste na modulação dos nìveis de reguladores angiogênicos de plaqueta, para a criação de um registro ou perfil de plaqueta para uma doença ou distúrbio angiogênico e para a monitoração da eficácia de uma terapia em um indivìduo com uma doença ou distúrbio angiogênico |
US20050272101A1 (en) * | 2004-06-07 | 2005-12-08 | Prasad Devarajan | Method for the early detection of renal injury |
CN101010001A (zh) * | 2004-05-06 | 2007-08-01 | 哥伦比亚大学受托人 | Ngal用于减少和改善局部缺血和肾中毒损伤 |
FR2872579B1 (fr) | 2004-06-30 | 2006-11-24 | Pasteur Institut | Detection de la tuberculose et de l'infection par mycobacterium tuberculosis a l'aide de hbha |
US20080038192A1 (en) * | 2004-07-19 | 2008-02-14 | Neurochem Inc. | Diagnostic Methods Of Multiple Organ Amyloidosis |
US7588892B2 (en) * | 2004-07-19 | 2009-09-15 | Entelos, Inc. | Reagent sets and gene signatures for renal tubule injury |
US7141382B1 (en) * | 2004-10-12 | 2006-11-28 | Parikh Chirag R | Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality |
WO2006083986A2 (en) | 2005-02-01 | 2006-08-10 | Government Of The U.S.A, As Represented By The Secretary Department Of Health & Human Services | Biomarkers for tissue status |
DE102005005872A1 (de) | 2005-02-09 | 2006-08-10 | Deutsche Thomson-Brandt Gmbh | Getaktete Stromversorgung |
EP2604703B1 (en) * | 2005-03-14 | 2017-02-01 | The Board of Trustees of the Leland Stanford Junior University | Methods for evaluating graft survival in a solid organ transplant recipient |
US7608413B1 (en) * | 2005-03-25 | 2009-10-27 | Celera Corporation | Kidney disease targets and uses thereof |
US20070037232A1 (en) * | 2005-03-31 | 2007-02-15 | Barasch Jonathan M | Detection of NGAL in chronic renal disease |
EP1877559B1 (en) * | 2005-04-18 | 2010-10-13 | Mitomics Inc. | Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers |
US20070087387A1 (en) * | 2005-04-21 | 2007-04-19 | Prasad Devarajan | Method for the Early Detection of Renal Disease Using Proteomics |
US20090178145A1 (en) | 2005-05-11 | 2009-07-09 | The Procter & Gamble Company | Methods and targets for identifying compounds for regulating angiogenesis |
JP4067557B2 (ja) * | 2005-06-03 | 2008-03-26 | 持田製薬株式会社 | 抗cd14抗体融合蛋白質 |
CA2614935A1 (en) * | 2005-07-21 | 2007-02-01 | The Johns Hopkins University | Methods of detecting and treating acute kidney injury |
US7759077B2 (en) * | 2005-08-02 | 2010-07-20 | Shariat Shahrokh F | Soluble fas urinary marker for the detection of bladder transitional cell carcinoma |
EP1757940A1 (en) * | 2005-08-26 | 2007-02-28 | Cézanne S.A.S. | In vitro method for diagnosing and monitoring renal cell carcinoma (RCC) using MMP-7 as humoral biomarker for RCC |
ES2331252T3 (es) * | 2005-09-20 | 2009-12-28 | Peter Jon Nelson | Inhibidor tisular de metaloproteinasas (timp) unido a anclajes de glucosilfosfatidilinositol (gpi) para el tratamiento del cancer. |
EP1931990A4 (en) | 2005-10-03 | 2010-03-10 | Biosite Inc | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND / OR FORECASTING IN SYSTEMIC INFLAMMATORY RESPONSE SYNDROMES |
US20080090304A1 (en) * | 2006-10-13 | 2008-04-17 | Barasch Jonathan Matthew | Diagnosis and monitoring of chronic renal disease using ngal |
US8329408B2 (en) * | 2005-10-31 | 2012-12-11 | Bayer Healthcare Llc | Methods for prognosis and monitoring cancer therapy |
US10716749B2 (en) * | 2005-11-03 | 2020-07-21 | Palo Alto Investors | Methods and compositions for treating a renal disease condition in a subject |
US20080133141A1 (en) * | 2005-12-22 | 2008-06-05 | Frost Stephen J | Weighted Scoring Methods and Use Thereof in Screening |
TW200726845A (en) * | 2006-01-02 | 2007-07-16 | Nat Defense Medical Ct | Biomarker molecular of renal illness and detecting method for the same |
KR20080085093A (ko) * | 2006-01-12 | 2008-09-22 | 얀센 파마슈티카 엔.브이. | 키마아제에 의한 slpi의 프로세싱 |
US20070203216A1 (en) * | 2006-02-14 | 2007-08-30 | Bjarke Ebert | Method of treating inflammatory diseases |
US7623910B2 (en) | 2006-03-10 | 2009-11-24 | University Of Rochester | ECG-based differentiation of LQT1 and LQT2 mutation |
GB0605217D0 (en) * | 2006-03-15 | 2006-04-26 | Novartis Ag | Method and compositions for assessing acute rejection |
GB0606776D0 (en) * | 2006-04-03 | 2006-05-10 | Novartis Pharma Ag | Predictive biomarkers for chronic allograft nephropathy |
GB0607943D0 (en) | 2006-04-21 | 2006-05-31 | Novartis Ag | Biomarkers for chronic transplant dysfunction |
US7662578B2 (en) * | 2006-04-21 | 2010-02-16 | Children's Hospital Medical Center | Method and kit for the early detection of impaired renal status |
US20080038269A1 (en) * | 2006-05-25 | 2008-02-14 | Mount Sinai Hospital | Methods for detecting and treating kidney disease |
WO2008084331A2 (en) | 2006-06-21 | 2008-07-17 | Hopitaux Universitaires De Geneve | Biomarkers for renal disorders |
WO2008005375A2 (en) * | 2006-06-30 | 2008-01-10 | Merck & Co., Inc. | Kidney toxicity biomarkers |
EP2049713A4 (en) * | 2006-07-21 | 2010-06-16 | Univ Alberta | TISSUE REJECTION |
GB0617429D0 (en) | 2006-09-05 | 2006-10-18 | Electrophoretics Ltd | Markers of renal transplant rejection and renal damage |
US20080206794A1 (en) * | 2006-09-15 | 2008-08-28 | Renovar Incorporated | Systems And Methods For Characterizing Contrast Induced-Nephropathy |
WO2008061149A2 (en) | 2006-11-14 | 2008-05-22 | Biosite Incorporated | Methods and compositions for diagnosis and prognosis of renal artery stenosis |
WO2008060607A2 (en) | 2006-11-14 | 2008-05-22 | Biosite Incorporated | Methods and compositions for monitoring and risk prediction in cardiorenal syndrome |
CA2665489C (en) * | 2006-12-08 | 2017-08-29 | The Children's Hospital Of Philadelphia | Prrg4-associated compositions and methods of use thereof in methods of tumor diagnosis |
GB0701626D0 (en) * | 2007-01-22 | 2007-03-07 | Cambridge Entpr Ltd | Methods and biomarkers for diagnosing and monitoring psychotic disorders |
WO2008104803A2 (en) | 2007-02-26 | 2008-09-04 | Oxford Genome Sciences (Uk) Limited | Proteins |
ES2430290T3 (es) | 2007-03-06 | 2013-11-19 | F. Hoffmann-La Roche Ag | Utilización de péptidos de tipo PNC para predecir la necesidad de diálisis |
JP5105583B2 (ja) * | 2007-03-14 | 2012-12-26 | 国立大学法人信州大学 | 心血管系疾患既往区別方法 |
US8221995B2 (en) * | 2007-03-23 | 2012-07-17 | Seok-Won Lee | Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes |
ES2397484T3 (es) | 2007-03-26 | 2013-03-07 | Novartis Ag | Biomarcadores predictivos de seguridad renal y firmas de biomarcadores para monitorizar la función renal |
WO2008122670A2 (en) | 2007-04-10 | 2008-10-16 | Integragen | Human diabetes susceptibility tnfrsf10b gene |
US8080394B2 (en) * | 2007-04-27 | 2011-12-20 | Brigham And Women's Hospital | Method for determining predisposition to pulmonary infection |
WO2008150488A1 (en) * | 2007-06-01 | 2008-12-11 | Laboratory Corporation Of America Holdings | Methods and systems for quantification of peptides and other analytes |
EP2160478B1 (en) | 2007-06-06 | 2014-08-27 | Siemens Healthcare Diagnostics Inc. | Predictive diagnostics for kidney disease |
US20090047689A1 (en) * | 2007-06-20 | 2009-02-19 | John Kolman | Autoantigen biomarkers for early diagnosis of lung adenocarcinoma |
US20100267041A1 (en) * | 2007-09-14 | 2010-10-21 | Predictive Biosciences, Inc. | Serial analysis of biomarkers for disease diagnosis |
WO2009038742A2 (en) | 2007-09-20 | 2009-03-26 | Caritas St. Elizabeth's Medical Center Of Boston, Inc. | Method for estimating risk of acute kidney injury |
US8039227B2 (en) * | 2007-09-20 | 2011-10-18 | University Of Louisville Research Foundation, Inc. | Peptide biomarkers predictive of renal function decline and kidney disease |
US8003333B2 (en) * | 2007-09-28 | 2011-08-23 | Mayo Foundation For Medical Education And Research | Serum biomarkers for early detection of acute cellular rejection |
BRPI0907802A2 (pt) | 2008-02-29 | 2016-08-23 | Univ Nagoya Nat Univ Corp | biomarcador para lesão renal aguda e estimativa de seu prognóstico, e sua aplicação |
WO2009146450A2 (en) * | 2008-05-30 | 2009-12-03 | Therapeutic Monitoring Services, L.L.C. | Methods for monitoring immunosuppressant drug levels, renal function, and hepatic function using small volume samples |
US8241861B1 (en) * | 2008-07-08 | 2012-08-14 | Insilicos, Llc | Methods and compositions for diagnosis or prognosis of cardiovascular disease |
US20110190156A1 (en) | 2008-07-15 | 2011-08-04 | Trustees Of Dartmouth College | Molecular signatures for diagnosing scleroderma |
EP2149613A1 (en) * | 2008-07-28 | 2010-02-03 | Greenwood Genetic Center, Inc. | Methods for determining dysregulation of methylation of brain expressed genes on the X chromosome to diagnose autism spectrum disorders |
WO2010022210A2 (en) * | 2008-08-21 | 2010-02-25 | Pxbiosciences Llc | Diagnosis and monitoring of renal failure using peptide biomarkers |
BRPI0917711A2 (pt) * | 2008-08-28 | 2017-06-20 | Astute Medical Inc | método para avaliar o estado renal em um paciente, e, uso de um ou mais marcadores de lesão renal |
WO2010025434A1 (en) | 2008-08-29 | 2010-03-04 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US8501489B2 (en) * | 2008-09-26 | 2013-08-06 | University of Pittsburgh—of the Commonwealth System of Higher Education | Urinary biomarkers to predict long-term dialysis |
EP3974836A1 (en) | 2008-10-21 | 2022-03-30 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CA2740923A1 (en) | 2008-10-21 | 2010-04-29 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
BRPI0922021A2 (pt) | 2008-11-10 | 2019-09-24 | Astute Medical Inc | método para avaliar a condição renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal |
US9229010B2 (en) * | 2009-02-06 | 2016-01-05 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
NZ594771A (en) | 2009-02-06 | 2013-06-28 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and failure |
WO2010111746A1 (en) | 2009-04-03 | 2010-10-07 | Vegenics Limited | Anti-vegf-d antibodies |
US20120183543A1 (en) | 2009-05-08 | 2012-07-19 | Novartis Ag | Diagnostic biomarkers for fibrotic disorders |
EP2462447A4 (en) * | 2009-08-07 | 2013-01-30 | Rules Based Medicine Inc | METHODS AND DEVICES FOR DETECTING RENAL INJURY |
NZ599105A (en) * | 2009-09-21 | 2014-08-29 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CA2784889C (en) | 2009-12-20 | 2018-06-19 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
NZ700695A (en) | 2010-02-05 | 2016-05-27 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US9029093B2 (en) | 2010-02-26 | 2015-05-12 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
AU2011269775B2 (en) | 2010-06-23 | 2015-01-15 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US20130210043A1 (en) | 2010-06-23 | 2013-08-15 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US20130035290A1 (en) * | 2011-05-17 | 2013-02-07 | Yale University | Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury |
EP3489690A1 (en) | 2011-08-26 | 2019-05-29 | Astute Medical, Inc. | Methods and compositions for evaluation of the renal status |
ES2734494T3 (es) | 2011-12-08 | 2019-12-10 | Astute Medical Inc | Métodos y usos para el diagnóstico de una lesión renal y de una insuficiencia renal |
CA3158996A1 (en) | 2013-01-17 | 2014-07-24 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
WO2014197729A1 (en) | 2013-06-05 | 2014-12-11 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
MX2016001573A (es) | 2013-08-07 | 2016-09-07 | Astute Medical Inc | Ensayos para timp2 con mejor rendimiento en muestras biológicas. |
CA2929547C (en) | 2013-11-06 | 2023-02-28 | Astute Medical, Inc. | Assays for igfbp7 having improved performance in biological samples |
WO2015084939A1 (en) | 2013-12-03 | 2015-06-11 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US11243202B2 (en) | 2015-04-09 | 2022-02-08 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CN109844526A (zh) | 2016-06-06 | 2019-06-04 | 机敏医药股份有限公司 | 使用胰岛素样生长因子结合蛋白7和金属蛋白酶2的组织抑制剂管理急性肾损伤 |
JP7100030B2 (ja) | 2016-10-28 | 2022-07-12 | アスチュート メディカル,インコーポレイテッド | 腎機能の改善のためのtimp-2に対する抗体の使用 |
WO2018145117A1 (en) | 2017-02-06 | 2018-08-09 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
JP7315466B2 (ja) | 2017-04-05 | 2023-07-26 | アスチュート メディカル,インコーポレイテッド | 生体試料中において改善した性能を有する、timp2に関するアッセイ |
WO2018208684A1 (en) | 2017-05-07 | 2018-11-15 | Astute Medical, Inc. | Use of insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 in the management of renal replacement therapy |
-
2009
- 2009-10-21 EP EP21192675.3A patent/EP3974836A1/en active Pending
- 2009-10-21 CN CN201410485610.5A patent/CN104391116B/zh not_active Expired - Fee Related
- 2009-10-21 BR BRPI0919640A patent/BRPI0919640A2/pt not_active IP Right Cessation
- 2009-10-21 CN CN200980149555.XA patent/CN102246035B/zh not_active Expired - Fee Related
- 2009-10-21 CN CN201310576168.2A patent/CN103760359B/zh active Active
- 2009-10-21 CN CN201410485595.4A patent/CN104391115B/zh not_active Expired - Fee Related
- 2009-10-21 JP JP2011532354A patent/JP2012506537A/ja active Pending
- 2009-10-21 NZ NZ607703A patent/NZ607703A/en not_active IP Right Cessation
- 2009-10-21 MX MX2011004174A patent/MX2011004174A/es active IP Right Grant
- 2009-10-21 EP EP20198819.3A patent/EP3783363A1/en not_active Withdrawn
- 2009-10-21 EP EP09822669A patent/EP2364444A4/en not_active Withdrawn
- 2009-10-21 KR KR1020117011445A patent/KR101760314B1/ko active IP Right Grant
- 2009-10-21 CN CN201410485543.7A patent/CN104399089B/zh not_active Expired - Fee Related
- 2009-10-21 EP EP17174892.4A patent/EP3246707B1/en active Active
- 2009-10-21 CN CN201610679757.7A patent/CN106370857A/zh active Pending
- 2009-10-21 WO PCT/US2009/061561 patent/WO2010048346A1/en active Application Filing
- 2009-10-21 AU AU2009308497A patent/AU2009308497B2/en active Active
- 2009-10-21 NZ NZ592358A patent/NZ592358A/xx not_active IP Right Cessation
- 2009-10-21 ES ES17174892T patent/ES2836218T3/es active Active
- 2009-10-21 NZ NZ628843A patent/NZ628843A/en not_active IP Right Cessation
- 2009-10-21 CA CA2740788A patent/CA2740788C/en active Active
- 2009-10-21 US US13/125,360 patent/US8778615B2/en active Active
-
2012
- 2012-01-05 HK HK12100122.7A patent/HK1159755A1/xx unknown
-
2014
- 2014-02-10 JP JP2014023208A patent/JP6247948B2/ja active Active
- 2014-07-09 US US14/327,513 patent/US10823733B2/en active Active
-
2016
- 2016-10-06 JP JP2016197891A patent/JP6400651B2/ja not_active Expired - Fee Related
-
2018
- 2018-09-05 JP JP2018166435A patent/JP6580227B2/ja active Active
-
2020
- 2020-10-30 US US17/085,566 patent/US11754566B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011004174A (es) | Metodos y composiciones para diagnosis y prognosis de lesion renal e insuficiencia renal. | |
MX341191B (es) | Metodos y composiciones para diagnostico y prognosis de lesion renal y falla renal. | |
SG10201407718WA (en) | Compounds and methods for kinase modulation, and indications therefor | |
MX342967B (es) | Metodos y composiciones para la diagnosis y prognosis de lesion renal y falla renal. | |
EP2743702A3 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
BRPI0413028A (pt) | composto, uso de um composto, composição farmacêutica, e, kit farmacêutico | |
SG162807A1 (en) | Azaindazole compounds and methods of use | |
MX2007003470A (es) | Compuestos de carbonilo los cuales pueden utilizarse como inhibidores del factor de coagulacion xa. | |
EP1773294A4 (en) | COMPOSITIONS FOR THE DELIVERY OF HIGHLY WATER-SOLUBLE DRUGS | |
IL201284A (en) | K3pi alpha pyridopyrimidinone inhibitor for use in combination with one or more therapeutic agents selected from Taxol, Rapamycin, Carboplatin and Arlutinib for cancer treatment | |
WO2007143211A3 (en) | Methods for identifying agents and their use for the prevention of restenosis | |
WO2007136790A3 (en) | Intracellular kinase inhibitors | |
GEP20115239B (en) | Pyrazoline compounds as mineralocorticoid receptor antagonists | |
EA200801046A1 (ru) | Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro | |
Yang et al. | Renal vasoconstrictor and pressor responses to angiotensin IV in mice are AT1a-receptor mediated | |
EE200100459A (et) | Ravimaine kombinatsioonis prootonpumba inhibiitori või H2 retseptori antagonistiga ning neid sisaldav farmatseutiline kompositsioon kasutamiseks mao-soolkonna häirete ravis | |
BRPI0707040B8 (pt) | Método in vitro de seleção de um composto, método in vitro de previsão da presença de câncer, método de determinação in vitro da eficiência de um tratamento anticancerígeno e uso de um composto | |
EP2527466A3 (en) | Genetic variants on CHR2 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment | |
EP2585826A4 (en) | METHODS AND COMPOSITIONS FOR DIAGNOSING AND PROGNOSING RENAL INJURY AND RENAL FAILURE | |
ATE531721T1 (de) | Cyanoaminochinolone als gsk-3-inhibitoren | |
WO2007076294A3 (en) | Method of screening the activity of the smoothened receptor to identify theraputic modulation agents or diagnose disease | |
GB2451987A (en) | Assessment of the effects of topical administration of chemodenervating pharmaceuticals | |
BRPI0512379A (pt) | composições farmacêuticas compreendendo inibidores de nep, inibidores do sistema de produção de endotelina endógena e antagonista do receptor at1 | |
Bracarda et al. | Protein kinase inhibitors in the treatment of renal cell carcinoma: sorafenib | |
MX2009004436A (es) | Derivados de quinazolina macrociclicos como inhibidores del factor de crecimiento endotelial vascular r3. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |